Technology & Operations > Biotechnology:
Strategies for Growth
Biotechnology:
Strategies for Growth
|
| Upcoming Sessions |
| |
None scheduled |
| |
|
| Key Benefits |
| During this course, you will: |
|
Become familiar with portfolio and resource allocation approaches |
|
Explore criteria which can be used to prioritize products and indications |
|
Learn how to transition from a sciencedriven to a market-driven organization |
|
Determine when to use or avoid mergers and acquisitions as value enhancement tools |
|
Examine how to structure alliances— what works and what does not work |
|
Develop a political and regulatory strategy for growth |
|
Learn how and when to communicate the value of biotech products and companies |
| |
"This program provided me with an excellent framework for understanding the various business models and how shareholder value is created in a biotech company."
Vice President-Risk, Life Science & Technology Finance, GE Commercial Finance |
|
|
|
Develop, assess, and communicate value-based corporate strategies for the identification, capture, and creation of value drivers in the complex and hyper-competitive biotech environment. Program topics include building value through capital; joint ventures, partnering, licensing, and other alliances; mergers and acquisitions; political and regulatory strategies; and the key linkages between strategy and perception of value.
The challenge is to know when and how to implement different critical tools to create a highly dynamic and resilient strategy—and the Kellogg School of Management’s world-class faculty will help you be more equipped to lead your biotech company to success.
View the faculty
|